Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 18.50
-0.56 (-2.94%)
At close: Jun 11, 2026
SHE:301263 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 25.67 | 28.63 | 108.22 | 153.5 | 174.61 | 120.07 |
Depreciation & Amortization | 65.37 | 65.37 | 54.42 | 39.04 | 33.07 | 28.25 |
Other Amortization | 1.39 | 1.39 | 0.65 | 0.62 | 0.76 | 1.06 |
Loss (Gain) From Sale of Assets | -0.19 | -0.19 | - | -0.15 | -0.01 | 0.02 |
Asset Writedown & Restructuring Costs | -3.46 | -3.46 | 1.27 | 7.61 | 0.3 | 3.34 |
Loss (Gain) From Sale of Investments | -0.91 | -0.91 | -2.9 | -8.5 | -9.97 | -0.27 |
Provision & Write-off of Bad Debts | 2.05 | 2.05 | -0.24 | 7.16 | 3.46 | - |
Other Operating Activities | 2.41 | 2.07 | 2.86 | 1.75 | 6.03 | 4.3 |
Change in Accounts Receivable | -51.98 | -51.98 | -28.87 | -70.77 | -64.03 | -55.86 |
Change in Inventory | 14.11 | 14.11 | -17.43 | -9.41 | -4.67 | 23.25 |
Change in Accounts Payable | -30.58 | -30.58 | -1.58 | -22.53 | 13.68 | 1.91 |
Change in Other Net Operating Assets | -2.34 | -2.34 | -0.54 | -3.47 | 0.58 | -0.58 |
Operating Cash Flow | -15.5 | -12.88 | 89.33 | 93.53 | 148.81 | 120.02 |
Operating Cash Flow Growth | - | - | -4.48% | -37.15% | 23.99% | -4.38% |
Capital Expenditures | -74.33 | -108.28 | -68.55 | -200.01 | -89.88 | -44.65 |
Sale of Property, Plant & Equipment | 0.03 | 0.02 | 0.01 | 0.09 | 0.01 | 0.1 |
Cash Acquisitions | - | - | - | -188.56 | - | - |
Investment in Securities | 12 | 82 | 129 | -11 | -263.13 | 0.27 |
Other Investing Activities | 2.64 | 1.87 | 5.8 | 8.55 | - | - |
Investing Cash Flow | -59.66 | -24.39 | 66.26 | -390.93 | -353.01 | -44.29 |
Short-Term Debt Issued | - | - | - | - | - | 107.51 |
Long-Term Debt Issued | - | 480.58 | 244.5 | 173.64 | 20 | - |
Total Debt Issued | 432.78 | 480.58 | 244.5 | 173.64 | 20 | 107.51 |
Short-Term Debt Repaid | - | - | - | - | - | -126.3 |
Long-Term Debt Repaid | - | -365.74 | -180.47 | -21.55 | -110.86 | -5.52 |
Total Debt Repaid | -398.18 | -365.74 | -180.47 | -21.55 | -110.86 | -131.82 |
Net Debt Issued (Repaid) | 34.59 | 114.83 | 64.03 | 152.09 | -90.86 | -24.31 |
Issuance of Common Stock | 257.36 | 257.36 | - | - | 1,078 | - |
Repurchase of Common Stock | - | - | - | -39 | - | - |
Common Dividends Paid | -94.45 | -93.58 | -135.12 | -166.78 | -85.81 | -4.27 |
Dividends Paid | -94.45 | -93.58 | -135.12 | -166.78 | -85.81 | -4.27 |
Other Financing Activities | -179.95 | -202.36 | - | - | -27.75 | -2.96 |
Financing Cash Flow | 17.56 | 76.25 | -71.09 | -53.69 | 873.44 | -31.54 |
Foreign Exchange Rate Adjustments | -0.07 | -0.03 | 0.01 | -0.05 | -0.08 | -0.08 |
Net Cash Flow | -57.68 | 38.95 | 84.52 | -351.14 | 669.17 | 44.12 |
Free Cash Flow | -89.83 | -121.16 | 20.78 | -106.48 | 58.94 | 75.38 |
Free Cash Flow Growth | - | - | - | - | -21.81% | 132.58% |
Free Cash Flow Margin | -13.22% | -17.95% | 2.88% | -14.00% | 7.52% | 11.53% |
Free Cash Flow Per Share | -0.19 | -0.25 | 0.04 | -0.21 | 0.12 | 0.20 |
Cash Income Tax Paid | 74.59 | 87.37 | 98.3 | 114.1 | 55.56 | 59.65 |
Levered Free Cash Flow | 8.21 | -76.11 | 82.8 | 10.05 | 23.05 | 43.07 |
Unlevered Free Cash Flow | 16.91 | -68.22 | 88.2 | 11.11 | 24.66 | 46.02 |
Change in Working Capital | -107.83 | -107.83 | -74.96 | -107.5 | -59.44 | -36.75 |